Ozempic Out-of-Pocket Cost: What You Pay Per Month

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

From the PlexusDx Education Hub, this guide explains what shapes your monthly Ozempic bill and how genetics inform the decision beneath it. Browse all Peptides & GLP-1 education

Ask five people what Ozempic costs and you may hear five answers, all of them technically true. The reason is that "out-of-pocket cost" is the end of a chain that starts at list price and passes through insurance, rebates, and pharmacy pricing. To make sense of the figure you will actually pay, it helps to see each link in that chain.

List price is only the starting line

As of April 2026, Ozempic's U.S. list price runs approximately $968 to $1,029 per month according to Novo Nordisk's published pricing. That number is almost never what an insured patient hands over at the counter. List price sits before insurance, rebates, manufacturer savings cards, and pharmacy negotiation all take their turns, which is why it functions as a ceiling rather than a real-world total.

How insurance reshapes the number

Commercial coverage hinges on whether the prescription is written for an FDA-approved indication and on your plan's formulary and prior authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes. Coverage for chronic weight management is far less uniform, frequently gated behind BMI-based prior authorization, and excluded outright by some plans. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though some products carry cardiovascular-indication coverage.

Savings cards and pharmacy coupons

Novo Nordisk publishes a manufacturer savings card that can meaningfully lower monthly cost for eligible commercially-insured patients. Government-funded coverage such as Medicare, Medicaid, and TRICARE is typically excluded, and the card carries monthly and annual caps that change over time. Independent discount platforms like GoodRx and SingleCare publish their own coupon prices, which vary from pharmacy to pharmacy. Verify current terms directly at the time of fill.

Three scenarios that explain the spread

Covered plan plus savings card

When a commercial plan covers the indication and the savings card applies, eligible patients may pay as little as $25 per month, depending on the plan's terms and caps.

Commercial plan, indication not covered

Here cash-pay costs move closer to list price minus whatever coupon applies, which is why the same drug can feel affordable to one person and expensive to another.

No insurance at all

Without coverage, out-of-pocket cost approaches list price, and compounded alternatives become a separate consideration with their own pricing.

Where compounded protocols sit

Licensed 503A compounding pharmacies produce compounded semaglutide and tirzepatide at price points separate from the branded drug. They are not identical to the brand and not generics. PlexusDx offers these through its Weight Management Protocols, available as Semaglutide Injection and other formats, with per-protocol pricing published on each product page.

The genetic layer under the cost question

Price tells you what a protocol costs; it says nothing about your own metabolic wiring. The Precision Peptide Genetic Test reviews 14 pathways, 49 peptides, 150+ genetic insights, including variants such as FTO and MC4R involved in appetite and energy balance. It does not predict response to any specific medication. It gives you trait-level context to discuss with your provider before spending on any protocol.

Questions to ask before you fill

Before paying, a few direct questions can prevent surprises. Ask the pharmacy for the exact price under your specific plan, not a general estimate, and whether a manufacturer savings card or independent coupon can be applied. Ask whether prior authorization is required and, if so, whether it has been approved. If you are comparing a compounded protocol, ask for the per-protocol price in writing. Because published pricing changes and eligibility rules shift, the figure that matters is the one confirmed at the moment of fill. Treating the counter as a place to verify rather than assume is the simplest way to avoid paying more than you needed to for the same prescription.

Frequently Asked Questions

What is the real out-of-pocket cost of Ozempic?

It varies widely. List price is roughly $968 to $1,029 per month as of April 2026, but insurance coverage, savings cards, and pharmacy pricing can move the counter total dramatically in either direction. The only reliable figure is the one your pharmacy quotes for your specific plan before the prescription is filled.

Why do people report paying $25 for Ozempic?

That low figure typically reflects a commercially-insured patient whose plan covers the indication and who qualifies for the manufacturer savings card. It depends on plan terms and card caps, and it does not apply to patients on Medicare, Medicaid, or TRICARE, who are generally excluded from the manufacturer program.

Does Medicare pay anything toward Ozempic?

Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026. Coverage tied to a cardiovascular indication exists for some products, and diabetes coverage differs from weight-management coverage. Because the rules are specific and change, confirm your own situation directly with your Medicare plan.

Are compounded versions cheaper out of pocket?

Compounded semaglutide and tirzepatide from licensed 503A pharmacies are priced separately from the FDA-approved brand and are legally and factually different, not generics. Whether they cost less depends on the pharmacy and protocol. PlexusDx publishes per-protocol pricing on each product page inside its Weight Management Protocols collection.

Keep exploring the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.